Latest Incyte News & Updates

See the latest news and media coverage for Incyte. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Incyte

Global biopharmaceutical company

incyte.com
Headquarters
Wilmington, United States
Company type
Public company
Number of employees
3,000–5,000

Last updated

Latest news about Incyte

In short: Incyte reported strong 2026 financial growth, advanced several key late-stage clinical programs, and expanded its pipeline through major acquisitions.

Company announcements

Incyte

Incyte to acquire Vega Therapeutics

The acquisition adds VGA039, a Phase 3 monoclonal antibody for von Willebrand disease, with $1.25B upfront and up to $750M in milestones.

Unlock all announcements with a

Media coverage

Yahoo Finance

Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with ...

New Positive Data Showed INCA033989 Achieved Rapid, Robust & Sustained Clinical & Molecular Responses and Was Well Tolerated in Patients with MF & ET...

Unlock all articles with a

Never miss news about Incyte

Track Incyte and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Incyte competitors & trending companies

Browse news for competitors to Incyte and other trending companies.